BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 28428219)

  • 1. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
    Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.
    Yan H; Niimi M; Matsuhisa F; Zhou H; Kitajima S; Chen Y; Wang C; Yang X; Yao J; Yang D; Zhang J; Murakami M; Nakajima K; Wang Y; Liu E; Liang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2095-2107. PubMed ID: 32757647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.
    Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).
    Rautureau Y; Deschambault V; Higgins MÈ; Rivas D; Mecteau M; Geoffroy P; Miquel G; Uy K; Sanchez R; Lavoie V; Brand G; Nault A; Williams PM; Suarez ML; Merlet N; Lapointe L; Duquette N; Gillis MA; Samami S; Mayer G; Pouliot P; Raignault A; Maafi F; Brodeur MR; Levesque S; Guertin MC; Dubé MP; Thorin É; Rhainds D; Rhéaume É; Tardif JC
    Circulation; 2018 Oct; 138(16):1677-1692. PubMed ID: 29674325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
    Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits.
    Gao S; Wang X; Cheng D; Li J; Li L; Ran L; Zhao S; Fan J; Liu E
    Mediators Inflamm; 2017; 2017():3824276. PubMed ID: 29317793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation.
    Yamashita S; Matsuzawa Y
    Curr Opin Lipidol; 2016 Oct; 27(5):459-72. PubMed ID: 27454452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit.
    Wu BJ; Shrestha S; Ong KL; Johns D; Hou L; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):628-36. PubMed ID: 25633313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Hepatic Expression of Endothelial Lipase Inhibits Cholesterol Diet-Induced Hypercholesterolemia and Atherosclerosis in Transgenic Rabbits.
    Wang C; Nishijima K; Kitajima S; Niimi M; Yan H; Chen Y; Ning B; Matsuhisa F; Liu E; Zhang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1282-1289. PubMed ID: 28546217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.
    Wang Y; Niimi M; Nishijima K; Waqar AB; Yu Y; Koike T; Kitajima S; Liu E; Inoue T; Kohashi M; Keyamura Y; Yoshikawa T; Zhang J; Ma L; Zha X; Watanabe T; Asada Y; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):224-31. PubMed ID: 23241412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
    Harder C; Lau P; Meng A; Whitman SC; McPherson R
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis.
    Wu BJ; Shrestha S; Ong KL; Johns D; Dunn LL; Hou L; Barter PJ; Rye KA
    Int J Cardiol; 2015 Nov; 199():204-12. PubMed ID: 26204569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
    Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vaccine targeted at CETP alleviates high fat and high cholesterol diet-induced atherosclerosis and non-alcoholic steatohepatitis in rabbit.
    Liaw YW; Lin CY; Lai YS; Yang TC; Wang CJ; Whang-Peng J; Liu LF; Lin CP; Nieh S; Lu SC; Hwang J
    PLoS One; 2014; 9(12):e111529. PubMed ID: 25486007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.
    Barter PJ; Brewer HB; Chapman MJ; Hennekens CH; Rader DJ; Tall AR
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):160-7. PubMed ID: 12588754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.